Graves’ disease is diagnosed through a combination of blood tests, antibody testing, and sometimes imaging. The process typically starts with a simple blood draw that checks thyroid hormone levels, then moves to more specific tests that confirm Graves’ as the cause rather than another thyroid condition.
Blood Tests Come First
The initial step is a blood test measuring three key values: thyroid-stimulating hormone (TSH), free T4, and T3. In Graves’ disease, TSH drops below normal while T4 and T3 rise above it. This pattern confirms hyperthyroidism, meaning your thyroid is overactive, but it doesn’t yet tell your doctor why. Several conditions can cause hyperthyroidism, including toxic nodules, thyroid inflammation, and Graves’ disease. The blood work narrows the field but doesn’t close the case on its own.
Antibody Tests That Pinpoint Graves’
What sets Graves’ disease apart from other causes of hyperthyroidism is that it’s autoimmune. Your immune system produces antibodies that latch onto thyroid cells and force the gland to overproduce hormones. Detecting those antibodies in your blood is the most direct way to confirm a Graves’ diagnosis.
Two antibody tests are commonly used. The thyrotropin receptor antibody test (TRAb) has a sensitivity of about 97% and specificity of 99%, meaning it catches nearly all true cases while rarely producing a false positive. The thyroid-stimulating immunoglobulin test (TSI) performs similarly, with sensitivity ranging from roughly 93% to 99% depending on the assay used. In practice, many labs run one or both of these. A positive result, combined with low TSH and elevated thyroid hormones, is usually enough to confirm Graves’ disease without any imaging at all.
What a Physical Exam Reveals
Your doctor will also look for physical signs that point specifically toward Graves’ rather than other thyroid conditions. Some of these signs are unique to Graves’ and don’t appear in other forms of hyperthyroidism.
About 25 to 30% of people with Graves’ disease develop eye changes known as thyroid eye disease. These can range from mild puffiness and redness around the eyes to more obvious signs like bulging eyes (proptosis), a visible widening of the eyelids, and difficulty moving the eyes normally. Only about 3% of cases progress to moderate or severe eye involvement. Your doctor may also listen to your thyroid with a stethoscope. A rushing sound called a bruit, caused by increased blood flow through the enlarged gland, is characteristic of Graves’.
Skin changes can also offer clues. Warm, moist skin with increased sweating is common in all forms of hyperthyroidism, but a thickened, orange-peel-textured patch of skin on the shins, called pretibial myxedema, is specific to Graves’. Hair thinning and patches of lost skin pigment (vitiligo) sometimes appear as well.
When Imaging Is Needed
If antibody results are unclear or unavailable, a radioactive iodine uptake test (RAIU) can distinguish Graves’ from other causes. You swallow a small capsule containing a trace amount of radioactive iodine, then return hours later for a scan that measures how much iodine your thyroid absorbed.
A healthy thyroid typically absorbs around 15% of the iodine. In Graves’ disease, uptake averages about 40%, with virtually no overlap between normal and Graves’ ranges. The uptake is also diffuse, meaning it spreads evenly across the entire gland rather than concentrating in one spot. This pattern distinguishes Graves’ from a toxic nodule, where only one area lights up, and from thyroiditis (thyroid inflammation), where uptake drops to very low levels, often around 3%.
This test isn’t appropriate for everyone. Pregnant or breastfeeding women can’t receive radioactive iodine, and people who’ve recently had CT scans with iodine-based contrast dye may get unreliable results. In those situations, a Doppler ultrasound offers an alternative. This painless scan measures blood flow through the arteries feeding the thyroid. In Graves’ disease, blood flow is dramatically increased. A peak velocity above 43 centimeters per second in the superior thyroid artery, combined with elevated blood flow through the thyroid tissue itself, has a positive predictive value of about 95% for Graves’ disease. Thyroiditis, by contrast, shows much lower flow in nearly all cases.
How Graves’ Looks Different From Similar Conditions
The reason diagnosis involves multiple steps is that several conditions can mimic Graves’ on initial blood work. A toxic multinodular goiter, for example, also causes low TSH and high thyroid hormones, but it tends to develop more gradually, with subtler symptoms. It won’t produce the same antibodies, and imaging will show hot spots in specific nodules rather than diffuse uptake across the whole gland.
Thyroiditis can also cause a temporary surge of thyroid hormones when an inflamed gland leaks its stored supply into the bloodstream. The blood work may look identical to Graves’ at first glance. The key differences: antibody tests for TRAb or TSI will be negative, radioactive iodine uptake will be very low instead of elevated, and the hyperthyroidism is usually temporary, resolving on its own within weeks to months. Graves’ disease, being autoimmune, persists until treated.
What the Diagnostic Timeline Looks Like
For most people, the process moves quickly. An initial blood draw for TSH and thyroid hormones can return results within a day or two. Antibody testing typically takes a few days to a week, depending on the lab. If those results are conclusive, you may have a confirmed diagnosis within one to two weeks of your first appointment.
If imaging is needed, a radioactive iodine uptake test requires two visits, one to take the capsule and one the next day for scanning, with results often available the same week. Ultrasound results are usually immediate. In straightforward cases with classic symptoms, positive antibodies, and clear blood work, many doctors feel confident diagnosing Graves’ disease without imaging at all.